JOHN REYES: Open Payments
NPI 1518142371 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 30 payments from 11 companies in 2025. Trend: 2023 $639 · 2024 $584 · 2025 $1,254
Food & beverage: $1,113Travel & lodging: $140
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $383 |
| ABBVIE INC. | 16 | $301 |
| BIOTRONIK NRO, Inc. | 1 | $149 |
| TAIHO ONCOLOGY, INC. | 1 | $125 |
| Abbott Laboratories | 1 | $103 |
| Merz Pharmaceuticals, LLC | 2 | $65 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Valinor Pharma, LLC | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
Products named: INTELLIS ADAPTIVESTIM, Prospera, UBRELVY, LONSURF, 2ND GEN CENTRIMAG PRIMARY CONSOLE, BOTOX, QULIPTA, Xeomin.
Industry payments across TX — which companies pay providers there.
